Glucosamine
8 benefits mapped to clinical evidence across supplements.
Dose per serving from products
110 products in our catalogue print how much Glucosamine a serving holds.
Most common: 1 g to 2.5 g, 25% of 110 products.
| Dose per serving | Products |
|---|---|
| 10 mg or less | 3 |
| 10 mg to 25 mg | 4 |
| 25 mg to 50 mg | 5 |
| 50 mg to 100 mg | 2 |
| 100 mg to 250 mg | 27 |
| 250 mg to 500 mg | 13 |
| 500 mg to 1 g | 27 |
| 1 g to 2.5 g | 28 |
| over 2.5 g | 1 |
Dose per serving from research
84 study groups in 64 studies say how much Glucosamine participants took a day.
These are the doses the studies gave. They are not a recommendation.
Most common: 1 g to 2.5 g, 74% of 84 study groups.
| Daily dose | Study groups |
|---|---|
| 500 mg or less | 5 |
| 500 mg to 1 g | 13 |
| 1 g to 2.5 g | 62 |
| over 2.5 g | 4 |
Commonly used together
36 of 85 study groups took Glucosamine with something else. Shown: what 3 or more different studies gave.
What was given together, not what works together.
| Taken with | Study groups |
|---|---|
| Chondroitin | 25 |
| Hyaluronic Acid | 7 |
| Turmeric | 3 |
Benefit Evidence
Research sources
Joint comfort (57)
- Comparison of the efficacy and tolerability of chondroitin plus glucosamine and D-002 (beeswax alcohols) in subjects with osteoarthritis symptoms
PubMed ID: 28657529
Glucosamine+chondroitin arm produced large WOMAC/VAS symptom reductions over 12 weeks (combo trial).
- Ayurvedic medicine offers a good alternative to glucosamine and celecoxib in the treatment of symptomatic knee osteoarthritis: a randomized, double-blind, controlled equivalence drug trial
PubMed ID: 23365148
Large RCT showed glucosamine sulfate clinically equivalent to active comparators for knee OA pain/symptoms.
- [Comparative efficacy of a combination of undenatured type II collagen, Boswellic acids, methylsulfonylmethane, vitamins C and D(3) and a combination of chondroitin sulfate and glucosamine hydrochloride in the treatment of primary osteoarthritis of the knee joint]
PubMed ID: 38785054
Knee OA outcomes improved with glucosamine+chondroitin in a 6‑month study.
- Glucosamine, chondroitin, and manganese ascorbate for degenerative joint disease of the knee or low back: a randomized, double-blind, placebo-controlled pilot study
PubMed ID: 10050562
Randomized crossover trial (glucosamine/chondroitin) reduced VAS pain and clinic disease scores in knee OA.
- Efficacy of a combination of FCHG49 glucosamine hydrochloride, TRH122 low molecular weight sodium chondroitin sulfate and manganese ascorbate in the management of knee osteoarthritis
PubMed ID: 10966840
RCT of glucosamine HCl+chondroitin produced significant symptom improvement and higher response rates vs placebo.
- [GAG for osteoarthritis of the knee--a prospective study]
PubMed ID: 10883158
IV glucosamine sulfate + chondroitin improved knee pain and function versus placebo.
- A randomized, double blind, placebo controlled trial of a topical cream containing glucosamine sulfate, chondroitin sulfate, and camphor for osteoarthritis of the knee
PubMed ID: 12610812
Topical G+CS RCT reduced knee pain/WOMAC vs placebo (confounded by other ingredients).
- [Combined medication ARTRA in the treatment of osteoarthrosis]
PubMed ID: 16404866
ARTRA (G+CS) RCT improved pain and allowed NSAID tapering in knee OA (combo product).
- Glucosamine and chondroitin for knee osteoarthritis: a double-blind randomised placebo-controlled clinical trial evaluating single and combination regimens
PubMed ID: 24395557
G+CS modestly slowed knee JSN over 2 years (structural benefit to knee joint health).
- Combined glucosamine and chondroitin sulfate, once or three times daily, provides clinically relevant analgesia in knee osteoarthritis
PubMed ID: 25085275
Large multicenter open study of G+CS formulations reported meaningful pain improvements (no placebo arm).
- Combined chondroitin sulfate and glucosamine for painful knee osteoarthritis: a multicentre, randomised, double-blind, non-inferiority trial versus celecoxib
PubMed ID: 25589511
Large RCT showing ~50% pain reduction with glucosamine+chondroitin vs baseline, directly supports improved comfort.
- Effects of glucosamine-chondroitin combination on synovial fluid IL-1β, IL-6, TNF-α and PGE2 levels in internal derangements of temporomandibular joint
PubMed ID: 25662545
TMJ pain was reduced significantly vs control, supporting decreased discomfort in that joint.
- [Use of ARTRA MSM FORTE in patients with knee osteoarthritis: Results of a randomized open-label comparative study of the efficacy and tolerability of the drug]
PubMed ID: 26978418
Combination product (glucosamine+chondroitin+MSM) produced faster symptomatic pain relief vs comparator.
- Glucosamine-containing supplement improves locomotor functions in subjects with knee pain: a randomized, double-blind, placebo-controlled study
PubMed ID: 26604721
Improved knee function and walking speed in symptomatic subgroup supports knee health.
- The efficacy and safety of a combination of glucosamine hydrochloride, chondroitin sulfate and bio-curcumin with exercise in the treatment of knee osteoarthritis: a randomized, double-blind, placebo-controlled study
PubMed ID: 26937646
Add-on supplement improved motion pain when combined with exercise in knee OA patients.
- Multicenter, randomized, double-blind clinical trial to evaluate efficacy and safety of combined glucosamine sulfate and chondroitin sulfate capsules for treating knee osteoarthritis
PubMed ID: 30657100
Randomized DB trial showing significant pain reduction and non-inferiority to reference product.
- Effectiveness of Cucumis sativus extract versus glucosamine-chondroitin in the management of moderate osteoarthritis: a randomized controlled trial
PubMed ID: 30498336
Moderate-sized trial with clinically relevant reductions in pain and function vs baseline.
- A Randomized, Double-Blind, Placebo-Controlled, Prospective Clinical Trial Evaluating Water-Soluble Chicken Eggshell Membrane for Improvement in Joint Health in Adults with Knee Osteoarthritis
PubMed ID: 31381494
Product containing glucosamine produced faster stiffness relief early, particularly in worse-off participants.
- Treatment of knee osteoarthritis with a new formulation of a fixed-dose combination of glucosamine sulfate and bovine chondroitin: a multicenter, randomized, single-blind, non-inferiority clinical trial
PubMed ID: 33468249
Large multicenter trial reporting substantial WOMAC pain reductions and high responder rates.
- The effect of oral low molecular weight liquid hyaluronic acid combination with glucosamine and chondroitin on knee osteoarthritis patients with mild knee pain: An 8-week randomized double-blind placebo-controlled trial
PubMed ID: 33592868
WOMAC stiffness improved significantly at 8 weeks in the HA+glucosamine+chondroitin group versus placebo (clear stiffness benefit for the combination product).
- Nutrition supplementation combined with exercise versus exercise alone in treating knee osteoarthritis: a double-blinded, randomised, placebo-controlled trial
PubMed ID: 39982001
Randomized trial of a nutrition formula containing glucosamine + exercise produced earlier and greater reductions in WOMAC pain (clinical symptom improvement).
- [Combination therapy for exacerbations of pain in osteoarthritis with non-fixed combinations]
PubMed ID: 40561485
Multi‑ingredient regimen including glucosamine + collagen produced substantially greater VAS/WOMAC pain reductions vs control regimen (clinical pain benefit in combination product).
- Effects of cartilage-supporting nutritional supplementation on knee osteoarthritis symptoms and quality of life in a 12-week randomized double-blind placebo-controlled pilot study
PubMed ID: 40664872
Pilot RCT of a multinutrient joint supplement including glucosamine showed within‑group symptom gains and some between‑group QoL/symptom signals (moderate support, product contained multiple actives).
- Effect of glucosamine sulfate with or without omega-3 fatty acids in patients with osteoarthritis
PubMed ID: 19756416
Adding omega‑3 to glucosamine increased the proportion with very large WOMAC pain improvement (combo benefit implies glucosamine is active within regimen).
- A commercialized dietary supplement alleviates joint pain in community adults: a double-blind, placebo-controlled community trial
PubMed ID: 24274358
Double‑blind RCT of a multi‑ingredient supplement (includes glucosamine) reduced WOMAC pain ~37% vs placebo (clinically meaningful pain relief for the product).
- Glucosamine sulfate in osteoarthritis of the knee
PubMed ID: 11548224
Oral glucosamine sulfate randomized trial showed significant symptom improvement (Lequesne index, responder rate) — strong direct evidence for improved joint comfort.
- Glucosamine sulfate compared to ibuprofen in osteoarthritis of the knee
PubMed ID: 11548225
Glucosamine produced symptom relief comparable to ibuprofen with fewer side effects — supports joint comfort.
- Efficacy and safety of intramuscular glucosamine sulfate in osteoarthritis of the knee. A randomised, placebo-controlled, double-blind study
PubMed ID: 8135881
Intramuscular glucosamine produced clinically meaningful symptomatic improvement and higher responder rate vs placebo.
- Efficacy and safety of glucosamine sulfate versus ibuprofen in patients with knee osteoarthritis
PubMed ID: 9638313
Randomized trial: glucosamine sulfate reduced knee OA symptoms comparably to ibuprofen with better tolerability and longer-lasting effect.
- Evaluation of glucosamine sulfate compared to ibuprofen for the treatment of temporomandibular joint osteoarthritis: a randomized double blind controlled 3 month clinical trial
PubMed ID: 11409130
Small TMJ OA RCT: glucosamine sulfate reduced pain with function and decreased rescue analgesic use.
- Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial
PubMed ID: 11214126
3-year RCT targeted knee OA and showed structural (JSW) preservation and symptom improvement.
- Glucosamine sulfate use and delay of progression of knee osteoarthritis: a 3-year, randomized, placebo-controlled, double-blind study
PubMed ID: 12374520
Large 3-year trial demonstrated prevention of joint-space narrowing and symptom benefit in knee OA.
- Correlation between radiographic severity of knee osteoarthritis and future disease progression. Results from a 3-year prospective, placebo-controlled study evaluating the effect of glucosamine sulfate
PubMed ID: 12505481
Subanalysis found glucosamine reduced radiographic progression in certain patient subgroups, relevant to knee health.
- The effect of glucosamine supplementation on people experiencing regular knee pain
PubMed ID: 12547742
12-week trial: large self-reported improvement (88% vs 17%) and better QoL on glucosamine.
- Glucosamine sulfate reduces osteoarthritis progression in postmenopausal women with knee osteoarthritis: evidence from two 3-year studies
PubMed ID: 15021442
3‑year knee OA RCT in postmenopausal women showed JSW preservation and symptom improvement — strong support for knee joint health.
- Effects of glucosamine administration on patients with rheumatoid arthritis
PubMed ID: 16953394
Small RA trial reported patient‑reported pain improvement and decreased MMP‑3 though objective counts unchanged — moderate symptomatic signal.
- Comparison of glucosamine sulfate and a polyherbal supplement for the relief of osteoarthritis of the knee: a randomized controlled trial [ISRCTN25438351]
PubMed ID: 17974032
8‑week trial reported large within‑group reductions in pain (WOMAC/VAS) with glucosamine sulfate — substantial symptomatic signal despite design limits.
- [Efficacy and safety evaluation of glucosamine hydrochloride in the treatment of osteoarthritis]
PubMed ID: 17961392
Multicenter 6‑week trial reported symptomatic improvement (HCl > sulfate by some measures) — moderate support for comfort.
- Total joint replacement after glucosamine sulphate treatment in knee osteoarthritis: results of a mean 8-year observation of patients from two previous 3-year, randomised, placebo-controlled trials
PubMed ID: 17681803
Long‑term follow‑up showed fewer total knee replacements among those randomized to glucosamine sulfate — strong evidence for knee health durability.
- Efficacy of a progressive walking program and glucosamine sulphate supplementation on osteoarthritic symptoms of the hip and knee: a feasibility trial
PubMed ID: 20152042
Feasibility trial: 6 weeks of glucosamine associated with symptomatic improvement (WOMAC stiffness/function).
- A clinical study on glucosamine sulfate versus combination of glucosamine sulfate and NSAIDs in mild to moderate knee osteoarthritis
PubMed ID: 22577354
Controlled clinical study: glucosamine improved WOMAC and VAS over 12 weeks (meaningful symptom relief).
- Kashin-Beck disease in Sichuan, China: report of a pilot open therapeutic trial
PubMed ID: 22157279
Open‑label improvement in VAS/WOMAC pain
- Green-lipped mussel extract (Perna canaliculus) and glucosamine sulphate in patients with knee osteoarthritis: therapeutic efficacy and effects on gastrointestinal microbiota profiles
PubMed ID: 22821424
Small OA trial showed symptom improvement
- Hyaluronic acid and glucosamine sulfate for adult Kashin-Beck disease: a cluster-randomized, placebo-controlled study
PubMed ID: 25388643
Placebo‑RCT showed reduced pain and improved symptoms
- The role of diet and exercise and of glucosamine sulfate in the prevention of knee osteoarthritis: Further results from the PRevention of knee Osteoarthritis in Overweight Females (PROOF) study
PubMed ID: 26806185
Lowered incident radiographic knee OA in prevention trial
- Comparison of the symptomatic and chondroprotective effects of glucosamine sulphate and exercise treatments in patients with knee osteoarthritis
PubMed ID: 25096309
Glucosamine improved pain similar to exercise
- Efficacy of glucosamine plus diacerein versus monotherapy of glucosamine: a double-blind, parallel randomized clinical trial
PubMed ID: 27729073
Knee OA trial: glucosamine groups improved pain (VAS) over time; supports symptomatic joint comfort though comparator question was diacerein addition.
- Glucosamine oral administration as an adjunct to hyaluronic acid injection in treating temporomandibular joint osteoarthritis
PubMed ID: 28862770
TMJ trial: oral glucosamine plus HA gave better long-term function and lowered pro‑inflammatory synovial cytokines, consistent with less pain/discomfort.
- Oral Glucosamine Hydrochloride Combined With Hyaluronate Sodium Intra-Articular Injection for Temporomandibular Joint Osteoarthritis: A Double-Blind Randomized Controlled Trial
PubMed ID: 29864430
TMJ RCT: oral glucosamine+HA produced better long-term pain relief vs HA alone — supports joint comfort in TMJ OA.
- Clinical efficacy of glucosamine hydrochloride tablets in the treatment of cervical spondylosis
PubMed ID: 30203748
Cervical spondylosis study: adding glucosamine to traction/exercise increased treatment response and satisfaction — symptomatic improvement signal.
- Milk-Fat Globule Membrane Plus Glucosamine Improves Joint Function and Physical Performance: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study
PubMed ID: 31257264
ROM improvements imply reduced perceived stiffness and improved range.
- "Efficacy and safety of Xinfeng capsule in the treatment of osteoarthritis: a multicenter, randomized, double-blinded, controlled trial"
PubMed ID: 32242394
4‑week OA trial: glucosamine produced symptom improvements comparable to active herbal comparator — supports short-term symptom benefit.
- The synergic use of the High Power Laser Therapy and Glucosamine sulfate in Knee osteoarthritis: A Randomized Controlled Trial
PubMed ID: 34212917
Glucosamine added to high-power laser therapy maintained greater pain relief at 6 months vs laser alone — supports durable symptom relief.
- Effect of celecoxib combined with glucosamine hydrochloride in promoting the functional recovery and decreasing the inflammatory factor levels in patients with knee osteoarthritis
PubMed ID: 34602400
Adjunct glucosamine improved pain/function and inflammatory markers in knee OA when added to celecoxib.
- Effects of ozone combined with articular injection of sodium hyaluronate on patients with knee osteoarthritis and their inflammatory factors and hemorheological indices
PubMed ID: 38223641
Knee OA combination (HA + oral glucosamine) produced marked VAS pain reductions — supports pain relief when used in that regimen.
- The Efficacy of Piascledine in Alleviating Symptoms and Its Impact on Blood Lipid Levels and body Mass Index in Patients with Knee Osteoarthritis
PubMed ID: 39981153
Large RCT: glucosamine sulfate produced substantial pain reduction vs baseline over 8 weeks — strong direct evidence for reduced joint pain.
- Comparative study of the efficacy of glucosamine sulfate capsules and Huoxue Xiaozhong prescription in the treatment of knee osteoarthritis and the recovery of knee joint function
PubMed ID: 40501230
Randomized comparison: glucosamine produced rapid pain relief and lowered inflammatory markers vs a TCM formula — supports symptomatic benefit.
Joint mobility (56)
- [Combined medication ARTRA in the treatment of osteoarthrosis]
PubMed ID: 16404866
ARTRA improved WOMAC function and reduced NSAID use, implying better mobility.
- Ayurvedic medicine offers a good alternative to glucosamine and celecoxib in the treatment of symptomatic knee osteoarthritis: a randomized, double-blind, controlled equivalence drug trial
PubMed ID: 23365148
24‑week RCT showed clinical equivalence of glucosamine sulfate for knee OA, including function endpoints.
- [Comparative efficacy of a combination of undenatured type II collagen, Boswellic acids, methylsulfonylmethane, vitamins C and D(3) and a combination of chondroitin sulfate and glucosamine hydrochloride in the treatment of primary osteoarthritis of the knee joint]
PubMed ID: 38785054
Both Artneo and glucosamine+chondroitin groups improved knee OA outcomes including function measures.
- Glucosamine, chondroitin, and manganese ascorbate for degenerative joint disease of the knee or low back: a randomized, double-blind, placebo-controlled pilot study
PubMed ID: 10050562
Observed improvements in clinic physical exam scores and functional disease scores.
- Efficacy of a combination of FCHG49 glucosamine hydrochloride, TRH122 low molecular weight sodium chondroitin sulfate and manganese ascorbate in the management of knee osteoarthritis
PubMed ID: 10966840
Significant functional/symptom benefit in mild‑moderate knee OA after 4–6 months on GS/CS combo.
- [GAG for osteoarthritis of the knee--a prospective study]
PubMed ID: 10883158
Reported improvement in knee range of motion with IV glucosamine sulfate + chondroitin.
- Effects of chondroitin sulfate and glucosamine in adult patients with Kaschin-Beck disease
PubMed ID: 20108108
Kashin–Beck RCT: G+CS prevented JSW loss over 8 months compared to placebo.
- Glucosamine and chondroitin for knee osteoarthritis: a double-blind randomised placebo-controlled clinical trial evaluating single and combination regimens
PubMed ID: 24395557
Two-year trial: G+CS produced a small but significant reduction in joint-space narrowing vs placebo.
- Combined glucosamine and chondroitin sulfate, once or three times daily, provides clinically relevant analgesia in knee osteoarthritis
PubMed ID: 25085275
Multicenter trial showed meaningful reductions in pain and Lequesne/functional scores across formulations.
- Efficacy of an oral hyaluronate and collagen supplement as a preventive treatment of elbow dysplasia
PubMed ID: 25234322
Preventive supplementation reduced radiographic elbow dysplasia incidence, implying improved resilience of developing joints (veterinary context).
- Combined chondroitin sulfate and glucosamine for painful knee osteoarthritis: a multicentre, randomised, double-blind, non-inferiority trial versus celecoxib
PubMed ID: 25589511
WOMAC function improved ~45% in large RCT — direct evidence of improved joint function.
- Effects of N-acetyl glucosamine and chondroitin sulfate supplementation on knee pain and self-reported knee function in middle-aged and older Japanese adults: a randomized, double-blind, placebo-controlled trial
PubMed ID: 26178634
JKOM knee function score improved significantly though VAS pain did not; supports function gains.
- Effects of glucosamine-chondroitin combination on synovial fluid IL-1β, IL-6, TNF-α and PGE2 levels in internal derangements of temporomandibular joint
PubMed ID: 25662545
TMJ study showed improved maximum mouth opening (flexibility of the joint) with glucosamine+chondroitin.
- [Use of ARTRA MSM FORTE in patients with knee osteoarthritis: Results of a randomized open-label comparative study of the efficacy and tolerability of the drug]
PubMed ID: 26978418
Earlier functional improvement and faster perceived pain relief suggest quicker return to easier movement.
- Glucosamine-containing supplement improves locomotor functions in subjects with knee pain: a randomized, double-blind, placebo-controlled study
PubMed ID: 26604721
Multi-component glucosamine-containing supplement improved walking speed and knee-extensor strength in symptomatic subgroup.
- The efficacy and safety of a combination of glucosamine hydrochloride, chondroitin sulfate and bio-curcumin with exercise in the treatment of knee osteoarthritis: a randomized, double-blind, placebo-controlled study
PubMed ID: 26937646
Lequesne index and WOMAC improved with supplement plus exercise, indicating function gain.
- Multicenter, randomized, double-blind clinical trial to evaluate efficacy and safety of combined glucosamine sulfate and chondroitin sulfate capsules for treating knee osteoarthritis
PubMed ID: 30657100
Significant pain reduction and investigator-rated analgesic efficacy suggest easier movement.
- Effectiveness of Cucumis sativus extract versus glucosamine-chondroitin in the management of moderate osteoarthritis: a randomized controlled trial
PubMed ID: 30498336
WOMAC and LFI improved over 6 months with glucosamine+chondroitin vs baseline.
- A Randomized, Double-Blind, Placebo-Controlled, Prospective Clinical Trial Evaluating Water-Soluble Chicken Eggshell Membrane for Improvement in Joint Health in Adults with Knee Osteoarthritis
PubMed ID: 31381494
6MWT and walking improvements seen in the worst-performing participants with eggshell-membrane product containing glucosamine.
- A randomised pilot equivalence trial to evaluate diamagnetically enhanced transdermal delivery of key ground substance components in comparison to an established transdermal non-steroidal anti-inflammatory formulation in males with prior knee injury
PubMed ID: 30794553
Topical device delivering glucosamine among other agents reduced pain more than diclofenac gel, which may ease movement, though skin AEs limit use.
- Treatment of knee osteoarthritis with a new formulation of a fixed-dose combination of glucosamine sulfate and bovine chondroitin: a multicenter, randomized, single-blind, non-inferiority clinical trial
PubMed ID: 33468249
Large RCT showed major pain/function improvements which translate to better mobility.
- The effect of oral low molecular weight liquid hyaluronic acid combination with glucosamine and chondroitin on knee osteoarthritis patients with mild knee pain: An 8-week randomized double-blind placebo-controlled trial
PubMed ID: 33592868
Significant improvements in WOMAC physical function and total at 8 weeks in the HA+glucosamine+chondroitin group (clear functional benefit for combination product).
- Nutrition supplementation combined with exercise versus exercise alone in treating knee osteoarthritis: a double-blinded, randomised, placebo-controlled trial
PubMed ID: 39982001
Supplement + exercise accelerated symptom and strength improvements relative to exercise alone, reflecting improved joint function in practice.
- [Combination therapy for exacerbations of pain in osteoarthritis with non-fixed combinations]
PubMed ID: 40561485
Regimen with glucosamine+collagen increased walking speed by ~12% and improved Timed Up‑and‑Go by ~42% (direct walking/ambulation benefits measured).
- Effects of cartilage-supporting nutritional supplementation on knee osteoarthritis symptoms and quality of life in a 12-week randomized double-blind placebo-controlled pilot study
PubMed ID: 40664872
Multinutrient product including glucosamine produced some KOOS function and sport/recreation gains (pilot evidence for functional mobility).
- Glucosamine but not ibuprofen alters cartilage turnover in osteoarthritis patients in response to physical training
PubMed ID: 19679221
Glucosamine reduced serum COMP levels in OA patients undergoing training, implying reduced cartilage matrix stress/turnover and potential resilience promotion.
- Evaluation of the effect of the administration of a glucosamine‑containing supplement on biomarkers for cartilage metabolism in soccer players: A randomized double‑blind placebo‑controlled study
PubMed ID: 30132529
Reductions in urinary CTX‑II and serum C2C with glucosamine indicate decreased collagen breakdown — a biomarker signal consistent with enhanced cartilage resilience.
- A commercialized dietary supplement alleviates joint pain in community adults: a double-blind, placebo-controlled community trial
PubMed ID: 24274358
Multi‑ingredient supplement containing glucosamine improved WOMAC function and total vs placebo (functional gains for the product).
- Glucosamine sulfate in osteoarthritis of the knee
PubMed ID: 11548224
Glucosamine sulfate RCT showed symptom and functional improvement (Lequesne index/responder rate) — supports improved mobility.
- Glucosamine sulfate compared to ibuprofen in osteoarthritis of the knee
PubMed ID: 11548225
Glucosamine produced symptom relief comparable to ibuprofen, supporting functional/mobility improvements with better tolerability.
- Efficacy and safety of glucosamine sulfate versus ibuprofen in patients with knee osteoarthritis
PubMed ID: 9638313
Symptom reduction vs ibuprofen implies functional/mobility benefit in knee OA.
- Evaluation of glucosamine sulfate compared to ibuprofen for the treatment of temporomandibular joint osteoarthritis: a randomized double blind controlled 3 month clinical trial
PubMed ID: 11409130
TMJ OA trial: greater sustained benefit on function vs ibuprofen in a small sample.
- Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial
PubMed ID: 11214126
Primary 3-year RCT end point: glucosamine sulfate markedly reduced joint-space narrowing vs placebo.
- Glucosamine sulfate use and delay of progression of knee osteoarthritis: a 3-year, randomized, placebo-controlled, double-blind study
PubMed ID: 12374520
Large 3-year randomized trial showed preservation of JSW vs placebo (clinically meaningful structural effect).
- Correlation between radiographic severity of knee osteoarthritis and future disease progression. Results from a 3-year prospective, placebo-controlled study evaluating the effect of glucosamine sulfate
PubMed ID: 12505481
Subanalysis: glucosamine associated with less JSN over 3 years in specific baseline-severity groups.
- Glucosamine sulfate reduces osteoarthritis progression in postmenopausal women with knee osteoarthritis: evidence from two 3-year studies
PubMed ID: 15021442
Direct evidence: 3‑year RCT showed preservation of joint‑space width vs placebo — strong support for maintaining joint structure.
- Comparison of glucosamine sulfate and a polyherbal supplement for the relief of osteoarthritis of the knee: a randomized controlled trial [ISRCTN25438351]
PubMed ID: 17974032
8‑week trial reported marked pain/function reductions (VAS/WOMAC) which would plausibly ease walking.
- Glucosamine sulfate in the treatment of knee osteoarthritis symptoms: a randomized, double-blind, placebo-controlled study using acetaminophen as a side comparator
PubMed ID: 17265490
6‑month RCT demonstrated statistically significant improvement in Lequesne and WOMAC responder rates — strong evidence for improved function.
- Total joint replacement after glucosamine sulphate treatment in knee osteoarthritis: results of a mean 8-year observation of patients from two previous 3-year, randomised, placebo-controlled trials
PubMed ID: 17681803
Long‑term follow‑up with substantially fewer total knee replacements supports sustained structural/clinically meaningful protection.
- A natural mineral supplement provides relief from knee osteoarthritis symptoms: a randomized controlled pilot trial
PubMed ID: 18279523
12‑week pilot reported improved walking distance in a small glucosamine arm — suggestive but limited evidence.
- [Effect of various intervention factors on MMP-3 and TIMP-1 level in synovial fluid in knee joints with osteroarthritis]
PubMed ID: 18245904
MMP‑3 decrease and TIMP‑1 increase indicate a biomarker profile favoring reduced cartilage degradation — supportive of structure maintenance.
- Efficacy of a progressive walking program and glucosamine sulphate supplementation on osteoarthritic symptoms of the hip and knee: a feasibility trial
PubMed ID: 20152042
Feasibility trial: objective function (Self‑Paced Step) improved ~13% after 6 weeks of glucosamine.
- A clinical study on glucosamine sulfate versus combination of glucosamine sulfate and NSAIDs in mild to moderate knee osteoarthritis
PubMed ID: 22577354
WOMAC function subscore and total score improved substantially with glucosamine over 12 weeks.
- Hyaluronic acid and glucosamine sulfate for adult Kashin-Beck disease: a cluster-randomized, placebo-controlled study
PubMed ID: 25388643
WOMAC function improved vs placebo
- The role of diet and exercise and of glucosamine sulfate in the prevention of knee osteoarthritis: Further results from the PRevention of knee Osteoarthritis in Overweight Females (PROOF) study
PubMed ID: 26806185
Significant reduction in incident radiographic knee OA
- Comparison of the symptomatic and chondroprotective effects of glucosamine sulphate and exercise treatments in patients with knee osteoarthritis
PubMed ID: 25096309
Pain/function improved similarly to exercise
- Efficacy of glucosamine plus diacerein versus monotherapy of glucosamine: a double-blind, parallel randomized clinical trial
PubMed ID: 27729073
Glucosamine groups improved on pain/function measures over 6 months suggesting easier movement, though study compared added diacerein.
- Glucosamine oral administration as an adjunct to hyaluronic acid injection in treating temporomandibular joint osteoarthritis
PubMed ID: 28862770
TMJ trial showed superior long‑term mouth opening (MMO) with glucosamine+HA — supports joint mobility.
- Oral Glucosamine Hydrochloride Combined With Hyaluronate Sodium Intra-Articular Injection for Temporomandibular Joint Osteoarthritis: A Double-Blind Randomized Controlled Trial
PubMed ID: 29864430
TMJ RCT: improved maximum interincisal opening at 12 months — improved jaw mobility (joint mobility example).
- Clinical efficacy of glucosamine hydrochloride tablets in the treatment of cervical spondylosis
PubMed ID: 30203748
Adjunct glucosamine in cervical spondylosis improved overall treatment effect and satisfaction — indicates functional/mobility benefit.
- Milk-Fat Globule Membrane Plus Glucosamine Improves Joint Function and Physical Performance: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study
PubMed ID: 31257264
Objective increases in passive and active ROM (knee, low back) indicate improved flexibility with MFGM+glucosamine.
- "Efficacy and safety of Xinfeng capsule in the treatment of osteoarthritis: a multicenter, randomized, double-blinded, controlled trial"
PubMed ID: 32242394
4‑week OA comparison: glucosamine improved WOMAC/function similar to active comparator — supports short‑term function gains.
- The synergic use of the High Power Laser Therapy and Glucosamine sulfate in Knee osteoarthritis: A Randomized Controlled Trial
PubMed ID: 34212917
Glucosamine + laser preserved pain/function improvements longer — indirectly supports maintained mobility over time.
- Effect of celecoxib combined with glucosamine hydrochloride in promoting the functional recovery and decreasing the inflammatory factor levels in patients with knee osteoarthritis
PubMed ID: 34602400
Combination with celecoxib produced larger Lequesne score improvements vs celecoxib alone — improved function signal.
- Effects of ozone combined with articular injection of sodium hyaluronate on patients with knee osteoarthritis and their inflammatory factors and hemorheological indices
PubMed ID: 38223641
Knee OA study: HSS functional score improved with HA+glucosamine — supports functional/mobility benefit.
- The Efficacy of Piascledine in Alleviating Symptoms and Its Impact on Blood Lipid Levels and body Mass Index in Patients with Knee Osteoarthritis
PubMed ID: 39981153
Large trial: substantial WOMAC functional score improvements over 8 weeks support improved joint function.
Daily comfort (31)
- Total joint replacement after glucosamine sulphate treatment in knee osteoarthritis: results of a mean 8-year observation of patients from two previous 3-year, randomised, placebo-controlled trials
PubMed ID: 17681803
Long‑term fewer knee replacements suggests downstream QoL/health resource benefits.
- Hyaluronic acid and glucosamine sulfate for adult Kashin-Beck disease: a cluster-randomized, placebo-controlled study
PubMed ID: 25388643
WOMAC/daily function improved vs placebo
- Comparison of the symptomatic and chondroprotective effects of glucosamine sulphate and exercise treatments in patients with knee osteoarthritis
PubMed ID: 25096309
Pain/function improvements that affect daily tasks
- Glucosamine oral administration as an adjunct to hyaluronic acid injection in treating temporomandibular joint osteoarthritis
PubMed ID: 28862770
Long‑term TMJ functional gains and favorable cytokine changes plausibly improve patient well‑being.
- Clinical efficacy of glucosamine hydrochloride tablets in the treatment of cervical spondylosis
PubMed ID: 30203748
Higher overall treatment efficiency and satisfaction with added glucosamine imply improved daily functioning for cervical spondylosis patients.
- Milk-Fat Globule Membrane Plus Glucosamine Improves Joint Function and Physical Performance: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study
PubMed ID: 31257264
Measured improvements in functional tasks (obstacle, stairs) indicate better daily activity capability.
- Effects of ozone combined with articular injection of sodium hyaluronate on patients with knee osteoarthritis and their inflammatory factors and hemorheological indices
PubMed ID: 38223641
HSS functional improvement suggests enhanced capacity for daily activities in knee OA.
- The Efficacy of Piascledine in Alleviating Symptoms and Its Impact on Blood Lipid Levels and body Mass Index in Patients with Knee Osteoarthritis
PubMed ID: 39981153
WOMAC and VAS improvements directly reflect better performance of daily activities in knee OA patients.
- Treatment of knee osteoarthritis with a new formulation of a fixed-dose combination of glucosamine sulfate and bovine chondroitin: a multicenter, randomized, single-blind, non-inferiority clinical trial
PubMed ID: 33468249
High responder rates and functional gains imply daily activities improved for many participants.
- The effect of oral low molecular weight liquid hyaluronic acid combination with glucosamine and chondroitin on knee osteoarthritis patients with mild knee pain: An 8-week randomized double-blind placebo-controlled trial
PubMed ID: 33592868
Large improvements in WOMAC pain and physical function at 8 weeks in the HA+glucosamine+chondroitin group indicate better ability to perform daily activities (direct functional benefit for the product).
- Nutrition supplementation combined with exercise versus exercise alone in treating knee osteoarthritis: a double-blinded, randomised, placebo-controlled trial
PubMed ID: 39982001
Supplement + exercise accelerated symptom/strength gains and higher MCID attainment for WOMAC total, implying improved daily function sooner.
- Effects of cartilage-supporting nutritional supplementation on knee osteoarthritis symptoms and quality of life in a 12-week randomized double-blind placebo-controlled pilot study
PubMed ID: 40664872
KOOS improvements in symptoms and sport/recreation and QoL were observed with a multinutrient product containing glucosamine (positive signal for daily activity quality).
- A commercialized dietary supplement alleviates joint pain in community adults: a double-blind, placebo-controlled community trial
PubMed ID: 24274358
Multi‑ingredient supplement including glucosamine improved WOMAC function and total vs placebo (improvements translate to daily activities).
- Glucosamine sulfate in osteoarthritis of the knee
PubMed ID: 11548224
Glucosamine sulfate RCT improved Lequesne index and responder rate — likely to translate into improved ability to perform daily activities in knee OA patients.
- Glucosamine sulfate compared to ibuprofen in osteoarthritis of the knee
PubMed ID: 11548225
Glucosamine provided symptomatic benefit comparable to ibuprofen with fewer adverse events — supports better daily functioning.
- Efficacy and safety of glucosamine sulfate versus ibuprofen in patients with knee osteoarthritis
PubMed ID: 9638313
Symptom/function benefit vs ibuprofen likely translates to improved daily activity ability.
- Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial
PubMed ID: 11214126
Long-term symptomatic benefits and slower structural deterioration consistent with QoL improvement.
- Glucosamine sulfate use and delay of progression of knee osteoarthritis: a 3-year, randomized, placebo-controlled, double-blind study
PubMed ID: 12374520
3-year RCT reported symptom improvements (~20–25%), likely translating to QoL benefit.
- The effect of glucosamine supplementation on people experiencing regular knee pain
PubMed ID: 12547742
KOOS QoL significantly better at weeks 8 and 12; large self-reported improvement vs placebo.
- Glucosamine sulfate reduces osteoarthritis progression in postmenopausal women with knee osteoarthritis: evidence from two 3-year studies
PubMed ID: 15021442
3‑year trial showed symptom improvement and JSW preservation in postmenopausal women — likely translates into improved QoL.
- Glucosamine sulfate in the treatment of knee osteoarthritis symptoms: a randomized, double-blind, placebo-controlled study using acetaminophen as a side comparator
PubMed ID: 17265490
6‑month trial demonstrated improved Lequesne/WOMAC and higher responder rate, consistent with better performance of daily activities.
- A clinical study on glucosamine sulfate versus combination of glucosamine sulfate and NSAIDs in mild to moderate knee osteoarthritis
PubMed ID: 22577354
WOMAC function and total score improvements imply better capacity for daily activities after glucosamine.
- [Combined medication ARTRA in the treatment of osteoarthrosis]
PubMed ID: 16404866
ARTRA reduced WOMAC/function and NSAID use, reflecting improved daily activities.
- Efficacy of a combination of FCHG49 glucosamine hydrochloride, TRH122 low molecular weight sodium chondroitin sulfate and manganese ascorbate in the management of knee osteoarthritis
PubMed ID: 10966840
Higher responder rates and symptom improvements imply gains in daily activity capability.
- Glucosamine, chondroitin, and manganese ascorbate for degenerative joint disease of the knee or low back: a randomized, double-blind, placebo-controlled pilot study
PubMed ID: 10050562
Improvements in clinical and diary VAS and exam scores indicate better ability to perform daily tasks.
- Ayurvedic medicine offers a good alternative to glucosamine and celecoxib in the treatment of symptomatic knee osteoarthritis: a randomized, double-blind, controlled equivalence drug trial
PubMed ID: 23365148
RCT demonstrated functional/symptomatic benefits relevant to daily activities in knee OA.
- Combined glucosamine and chondroitin sulfate, once or three times daily, provides clinically relevant analgesia in knee osteoarthritis
PubMed ID: 25085275
Multicenter trial reported Lequesne/function improvements that translate to daily activity gains.
- Combined chondroitin sulfate and glucosamine for painful knee osteoarthritis: a multicentre, randomised, double-blind, non-inferiority trial versus celecoxib
PubMed ID: 25589511
Large WOMAC function improvements indicate better performance of daily activities.
- Effects of N-acetyl glucosamine and chondroitin sulfate supplementation on knee pain and self-reported knee function in middle-aged and older Japanese adults: a randomized, double-blind, placebo-controlled trial
PubMed ID: 26178634
Household physical activity increased and JKOM (knee function) improved with N‑acetyl glucosamine + chondroitin.
- Multicenter, randomized, double-blind clinical trial to evaluate efficacy and safety of combined glucosamine sulfate and chondroitin sulfate capsules for treating knee osteoarthritis
PubMed ID: 30657100
Significant pain reduction and favorable efficacy ratings would support improved daily function.
- Effectiveness of Cucumis sativus extract versus glucosamine-chondroitin in the management of moderate osteoarthritis: a randomized controlled trial
PubMed ID: 30498336
WOMAC and VAS improvements over 6 months imply modest QoL gains.
Healthy aging (20)
- The role of diet and exercise and of glucosamine sulfate in the prevention of knee osteoarthritis: Further results from the PRevention of knee Osteoarthritis in Overweight Females (PROOF) study
PubMed ID: 26806185
Reduced incident radiographic knee OA in middle‑aged overweight women
- Glucosamine, chondroitin, and manganese ascorbate for degenerative joint disease of the knee or low back: a randomized, double-blind, placebo-controlled pilot study
PubMed ID: 10050562
Symptom/function improvements in OA patients support use in age‑related joint complaints.
- Efficacy of a combination of FCHG49 glucosamine hydrochloride, TRH122 low molecular weight sodium chondroitin sulfate and manganese ascorbate in the management of knee osteoarthritis
PubMed ID: 10966840
Beneficial effects in mild‑to‑moderate OA suggest relevance to management of aging joints.
- [Combined medication ARTRA in the treatment of osteoarthrosis]
PubMed ID: 16404866
ARTRA improved function and reduced NSAID need in women with knee OA, relevant to aging-joint symptom management.
- Effects of chondroitin sulfate and glucosamine in adult patients with Kaschin-Beck disease
PubMed ID: 20108108
Kashin–Beck disease study showed preserved JSW with G+CS over 8 months (structural support).
- Glucosamine and chondroitin for knee osteoarthritis: a double-blind randomised placebo-controlled clinical trial evaluating single and combination regimens
PubMed ID: 24395557
G+CS modestly slowed JSN over 2 years, suggesting structural support relevant to aging joints.
- Efficacy of an oral hyaluronate and collagen supplement as a preventive treatment of elbow dysplasia
PubMed ID: 25234322
Preventive supplementation in puppies reduced later elbow dysplasia, implying long-term joint-protective potential (veterinary context).
- Clinical risk factors associated with radiographic osteoarthritis progression among people with knee pain: a longitudinal study
PubMed ID: 34088340
Large longitudinal analysis in a glucosamine/chondroitin trial cohort identified factors linked to radiographic progression; provides context for interventions aimed at aging joints (observational structural context).
- Glucosamine sulfate in osteoarthritis of the knee
PubMed ID: 11548224
Glucosamine sulfate RCT improved symptoms/function in knee OA, supporting use for symptom management in aging joints though structural disease‑modifying evidence limited.
- Glucosamine sulfate compared to ibuprofen in osteoarthritis of the knee
PubMed ID: 11548225
Glucosamine comparable to ibuprofen for symptoms with fewer AEs — supports symptomatic care in aging joints.
- Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial
PubMed ID: 11214126
Long-term structural preservation and symptomatic benefit in knee OA aligns with supporting aging joints.
- Glucosamine sulfate use and delay of progression of knee osteoarthritis: a 3-year, randomized, placebo-controlled, double-blind study
PubMed ID: 12374520
3-year evidence of preventing JSW loss supports benefit for degenerative (aging) joint processes.
- Correlation between radiographic severity of knee osteoarthritis and future disease progression. Results from a 3-year prospective, placebo-controlled study evaluating the effect of glucosamine sulfate
PubMed ID: 12505481
Subanalysis showed reduced JSN particularly in less severe baseline OA — relevant to early aging joints.
- Glucosamine sulfate reduces osteoarthritis progression in postmenopausal women with knee osteoarthritis: evidence from two 3-year studies
PubMed ID: 15021442
3‑year structural preservation and symptom improvement in postmenopausal women indicate benefit for ageing joints.
- Total joint replacement after glucosamine sulphate treatment in knee osteoarthritis: results of a mean 8-year observation of patients from two previous 3-year, randomised, placebo-controlled trials
PubMed ID: 17681803
Long‑term lower knee‑replacement incidence implies disease‑modifying or delaying effects relevant to aging joints.
- Hyaluronic acid and glucosamine sulfate for adult Kashin-Beck disease: a cluster-randomized, placebo-controlled study
PubMed ID: 25388643
Improved symptoms/function in joint disease population
- Milk-Fat Globule Membrane Plus Glucosamine Improves Joint Function and Physical Performance: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study
PubMed ID: 31257264
Study in older adults with mild joint pain showed improved ROM and physical performance with MFGM+glucosamine — supportive for aging joints.
- Effects of ozone combined with articular injection of sodium hyaluronate on patients with knee osteoarthritis and their inflammatory factors and hemorheological indices
PubMed ID: 38223641
Knee OA biochemical and functional improvements with HA+glucosamine indicate potential supportive effects in degenerative joints.
- The Efficacy of Piascledine in Alleviating Symptoms and Its Impact on Blood Lipid Levels and body Mass Index in Patients with Knee Osteoarthritis
PubMed ID: 39981153
Large OA trial in adults with knee OA shows symptom/function improvements applicable to older individuals with joint degeneration.
- Ayurvedic medicine offers a good alternative to glucosamine and celecoxib in the treatment of symptomatic knee osteoarthritis: a randomized, double-blind, controlled equivalence drug trial
PubMed ID: 23365148
Large RCT in knee OA population (commonly older adults) supports symptomatic joint benefit relevant to aging joints.
Wellbeing (18)
- Glucosamine sulfate compared to ibuprofen in osteoarthritis of the knee
PubMed ID: 11548225
Symptomatic relief comparable to ibuprofen with fewer AEs supports potential to sustain activity levels through symptomatic control.
- A clinical study on glucosamine sulfate versus combination of glucosamine sulfate and NSAIDs in mild to moderate knee osteoarthritis
PubMed ID: 22577354
Improved pain and function over 12 weeks enables greater activity participation in knee OA patients.
- Hyaluronic acid and glucosamine sulfate for adult Kashin-Beck disease: a cluster-randomized, placebo-controlled study
PubMed ID: 25388643
Reduced pain and improved function can facilitate activity
- The role of diet and exercise and of glucosamine sulfate in the prevention of knee osteoarthritis: Further results from the PRevention of knee Osteoarthritis in Overweight Females (PROOF) study
PubMed ID: 26806185
Prevention of OA helps sustain activity over time
- Comparison of the symptomatic and chondroprotective effects of glucosamine sulphate and exercise treatments in patients with knee osteoarthritis
PubMed ID: 25096309
Symptom improvements may allow activity maintenance
- Milk-Fat Globule Membrane Plus Glucosamine Improves Joint Function and Physical Performance: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study
PubMed ID: 31257264
Improved ROM and faster functional tasks enable more active behavior among older adults — supports activity.
- Effects of ozone combined with articular injection of sodium hyaluronate on patients with knee osteoarthritis and their inflammatory factors and hemorheological indices
PubMed ID: 38223641
Functional improvements and reduced joint inflammation support engagement in activity when used as part of combination therapy.
- The Efficacy of Piascledine in Alleviating Symptoms and Its Impact on Blood Lipid Levels and body Mass Index in Patients with Knee Osteoarthritis
PubMed ID: 39981153
Reduced pain and improved function in knee OA likely facilitate continued activity.
- The effect of oral low molecular weight liquid hyaluronic acid combination with glucosamine and chondroitin on knee osteoarthritis patients with mild knee pain: An 8-week randomized double-blind placebo-controlled trial
PubMed ID: 33592868
Combination product improved pain and function over 8 weeks, which could enable greater physical activity (indirect).
- Glucosamine-containing supplement improves locomotor functions in subjects with knee pain: a randomized, double-blind, placebo-controlled study
PubMed ID: 26604721
Improved walking speed and strength in symptomatic subgroup can facilitate a more active lifestyle.
- [Use of ARTRA MSM FORTE in patients with knee osteoarthritis: Results of a randomized open-label comparative study of the efficacy and tolerability of the drug]
PubMed ID: 26978418
Faster symptomatic improvement and earlier functional gains support activity participation.
- Combined chondroitin sulfate and glucosamine for painful knee osteoarthritis: a multicentre, randomised, double-blind, non-inferiority trial versus celecoxib
PubMed ID: 25589511
Large reductions in pain and function limitations support maintained activity.
- [Combined medication ARTRA in the treatment of osteoarthrosis]
PubMed ID: 16404866
Improved pain/function and reduced NSAID use may facilitate activity participation.
- Ayurvedic medicine offers a good alternative to glucosamine and celecoxib in the treatment of symptomatic knee osteoarthritis: a randomized, double-blind, controlled equivalence drug trial
PubMed ID: 23365148
Symptom and function benefits with glucosamine sulfate support continued activity in OA patients.
- Nutrition supplementation combined with exercise versus exercise alone in treating knee osteoarthritis: a double-blinded, randomised, placebo-controlled trial
PubMed ID: 39982001
Supplement containing glucosamine + exercise led to faster attainment of clinical improvement and strength gains vs exercise alone — supports maintaining activity levels and earlier return to performance.
- [Combination therapy for exacerbations of pain in osteoarthritis with non-fixed combinations]
PubMed ID: 40561485
Improvements in walking speed and TUG after regimen including glucosamine+collagen support better capacity for daily activities and active living.
- A commercialized dietary supplement alleviates joint pain in community adults: a double-blind, placebo-controlled community trial
PubMed ID: 24274358
Product including glucosamine reduced pain and improved function, facilitating activity participation (clinical product evidence).
- Glucosamine sulfate in osteoarthritis of the knee
PubMed ID: 11548224
Glucosamine sulfate improved symptoms/function (Lequesne/responder) in knee OA, which plausibly supports maintaining a more active lifestyle in affected patients.
Joints & tendons (15)
- Effects of chondroitin sulfate and glucosamine in adult patients with Kaschin-Beck disease
PubMed ID: 20108108
Kashin–Beck disease trial: G+CS slowed JSW loss over 8 months (structural preservation).
- Effects of ozone combined with articular injection of sodium hyaluronate on patients with knee osteoarthritis and their inflammatory factors and hemorheological indices
PubMed ID: 38223641
Joint‑fluid markers (MMP‑13, IL‑1β, IL‑6, TNF‑α) decreased when HA + oral glucosamine used — biochemical signals consistent with cartilage protective environment.
- Milk-Fat Globule Membrane Plus Glucosamine Improves Joint Function and Physical Performance: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study
PubMed ID: 31257264
Functional and ROM improvements imply benefits to joint/connective tissue performance when glucosamine is provided in combination product.
- Glucosamine oral administration as an adjunct to hyaluronic acid injection in treating temporomandibular joint osteoarthritis
PubMed ID: 28862770
Synovial cytokine changes (↓IL‑1β/IL‑6, ↑TGF‑β) with oral glucosamine+HA suggest a joint milieu favorable to cartilage maintenance.
- The role of diet and exercise and of glucosamine sulfate in the prevention of knee osteoarthritis: Further results from the PRevention of knee Osteoarthritis in Overweight Females (PROOF) study
PubMed ID: 26806185
Prevention trial reduced incident radiographic knee OA
- [Effect of various intervention factors on MMP-3 and TIMP-1 level in synovial fluid in knee joints with osteroarthritis]
PubMed ID: 18245904
Glucosamine‑containing treatments lowered MMP‑3 and increased TIMP‑1 in synovial fluid — biomarker changes consistent with reduced cartilage breakdown.
- Total joint replacement after glucosamine sulphate treatment in knee osteoarthritis: results of a mean 8-year observation of patients from two previous 3-year, randomised, placebo-controlled trials
PubMed ID: 17681803
5–8 year follow‑up found fewer total knee replacements in glucosamine recipients — indirect long‑term support for structural benefit.
- Glucosamine sulfate reduces osteoarthritis progression in postmenopausal women with knee osteoarthritis: evidence from two 3-year studies
PubMed ID: 15021442
3‑year randomized data in postmenopausal women showed preservation of joint‑space width vs placebo — strong direct evidence of cartilage/structural support.
- Correlation between radiographic severity of knee osteoarthritis and future disease progression. Results from a 3-year prospective, placebo-controlled study evaluating the effect of glucosamine sulfate
PubMed ID: 12505481
Subanalysis: glucosamine associated with less joint-space narrowing over 3 years in certain baseline-severity groups.
- Glucosamine sulfate use and delay of progression of knee osteoarthritis: a 3-year, randomized, placebo-controlled, double-blind study
PubMed ID: 12374520
Large 3-year trial showed prevention of JSW loss vs placebo (JSW ~+0.23 mm difference), supporting cartilage protection.
- Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial
PubMed ID: 11214126
Three-year RCT: glucosamine sulfate markedly reduced joint-space narrowing (~0.25 mm less loss), indicating cartilage-structure preservation.
- Evaluation of the effect of the administration of a glucosamine‑containing supplement on biomarkers for cartilage metabolism in soccer players: A randomized double‑blind placebo‑controlled study
PubMed ID: 30132529
Placebo‑controlled study in healthy athletes reported decreased urinary CTX‑II and serum C2C with 2 g/day glucosamine over 16 weeks (direct biomarker evidence of reduced type II collagen degradation).
- Glucosamine but not ibuprofen alters cartilage turnover in osteoarthritis patients in response to physical training
PubMed ID: 19679221
Randomized trial in OA patients doing strength training showed glucosamine added a ~13% reduction in serum COMP (a cartilage turnover marker), indicating chondroprotective signal.
- Efficacy of an oral hyaluronate and collagen supplement as a preventive treatment of elbow dysplasia
PubMed ID: 25234322
Puppy study reported reduced incidence of elbow dysplasia radiographically after early multisupplement including glucosamine.
- Glucosamine and chondroitin for knee osteoarthritis: a double-blind randomised placebo-controlled clinical trial evaluating single and combination regimens
PubMed ID: 24395557
Large RCT: G+CS modestly slowed radiographic joint-space narrowing over 2 years (structural signal).
Muscle soreness (14)
- Hyaluronic acid and glucosamine sulfate for adult Kashin-Beck disease: a cluster-randomized, placebo-controlled study
PubMed ID: 25388643
Pain reductions likely reduce activity‑related soreness
- [Combined medication ARTRA in the treatment of osteoarthrosis]
PubMed ID: 16404866
ARTRA decreased pain and NSAID need, suggesting less activity-related soreness.
- Efficacy of a combination of FCHG49 glucosamine hydrochloride, TRH122 low molecular weight sodium chondroitin sulfate and manganese ascorbate in the management of knee osteoarthritis
PubMed ID: 10966840
Treatment produced clinically meaningful pain relief in mild/moderate knee OA, which would include activity‑related soreness.
- Glucosamine, chondroitin, and manganese ascorbate for degenerative joint disease of the knee or low back: a randomized, double-blind, placebo-controlled pilot study
PubMed ID: 10050562
Reductions in VAS pain and disease scores indicate decreased soreness associated with activity.
- The Efficacy of Piascledine in Alleviating Symptoms and Its Impact on Blood Lipid Levels and body Mass Index in Patients with Knee Osteoarthritis
PubMed ID: 39981153
Marked decreases in VAS pain and WOMAC suggest less soreness associated with activity in knee OA participants.
- A clinical study on glucosamine sulfate versus combination of glucosamine sulfate and NSAIDs in mild to moderate knee osteoarthritis
PubMed ID: 22577354
WOMAC and VAS pain improvements would be expected to reduce soreness associated with activity in knee OA patients.
- Milk-Fat Globule Membrane Plus Glucosamine Improves Joint Function and Physical Performance: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study
PubMed ID: 31257264
Improved ROM and functional task speeds indicate reduced discomfort during activity.
- Comparison of glucosamine sulfate and a polyherbal supplement for the relief of osteoarthritis of the knee: a randomized controlled trial [ISRCTN25438351]
PubMed ID: 17974032
Marked short‑term pain reductions reported could reflect reduced post‑activity soreness, though trial lacked placebo and attribution is limited.
- The synergic use of the High Power Laser Therapy and Glucosamine sulfate in Knee osteoarthritis: A Randomized Controlled Trial
PubMed ID: 34212917
More durable pain relief with glucosamine + laser implies lower recurrence of activity‑related soreness.
- Efficacy and safety of glucosamine sulfate versus ibuprofen in patients with knee osteoarthritis
PubMed ID: 9638313
Glucosamine sulfate reduced OA symptoms (including pain with movement) comparable to ibuprofen in RCT.
- Nutrition supplementation combined with exercise versus exercise alone in treating knee osteoarthritis: a double-blinded, randomised, placebo-controlled trial
PubMed ID: 39982001
Supplement + exercise group achieved earlier clinical improvement and some strength gains relative to exercise alone, suggesting reduced symptom burden and soreness during activity/recovery.
- The efficacy and safety of a combination of glucosamine hydrochloride, chondroitin sulfate and bio-curcumin with exercise in the treatment of knee osteoarthritis: a randomized, double-blind, placebo-controlled study
PubMed ID: 26937646
Supplement added to exercise reduced motion pain and algofunctional scores compared with placebo + exercise.
- [Use of ARTRA MSM FORTE in patients with knee osteoarthritis: Results of a randomized open-label comparative study of the efficacy and tolerability of the drug]
PubMed ID: 26978418
Earlier pain relief and functional gains suggest reduced activity-related soreness after treatment with GC+MSM formulation.
- Combined chondroitin sulfate and glucosamine for painful knee osteoarthritis: a multicentre, randomised, double-blind, non-inferiority trial versus celecoxib
PubMed ID: 25589511
Large pain reductions on WOMAC imply less soreness with activity in treated patients.
Illness recovery (8)
- The efficacy and safety of a combination of glucosamine hydrochloride, chondroitin sulfate and bio-curcumin with exercise in the treatment of knee osteoarthritis: a randomized, double-blind, placebo-controlled study
PubMed ID: 26937646
Already listed; added here because the study explicitly demonstrates earlier motion improvements (duplicate rationale).
- The Efficacy of Piascledine in Alleviating Symptoms and Its Impact on Blood Lipid Levels and body Mass Index in Patients with Knee Osteoarthritis
PubMed ID: 39981153
Rapid improvements in VAS and WOMAC by 4–8 weeks suggest quicker symptomatic recovery enabling earlier activity resumption.
- The synergic use of the High Power Laser Therapy and Glucosamine sulfate in Knee osteoarthritis: A Randomized Controlled Trial
PubMed ID: 34212917
Combination with laser therapy led to more durable pain relief, which may speed return to activity relative to laser alone.
- Milk-Fat Globule Membrane Plus Glucosamine Improves Joint Function and Physical Performance: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study
PubMed ID: 31257264
Improved performance measures (obstacle walking, stair speed) indicate better short‑term functional recovery in older adults.
- [Combination therapy for exacerbations of pain in osteoarthritis with non-fixed combinations]
PubMed ID: 40561485
Combination regimen including glucosamine+collagen yielded relatively large and rapid gains in pain and function vs regimen without collagen (suggests quicker symptomatic recovery for combined product).
- Nutrition supplementation combined with exercise versus exercise alone in treating knee osteoarthritis: a double-blinded, randomised, placebo-controlled trial
PubMed ID: 39982001
Nutrition supplement containing glucosamine + exercise produced faster time to clinical improvement and earlier strength gains vs exercise alone (evidence of faster recovery of function/symptoms).
- Multicenter, randomized, double-blind clinical trial to evaluate efficacy and safety of combined glucosamine sulfate and chondroitin sulfate capsules for treating knee osteoarthritis
PubMed ID: 30657100
12-week trial showed significant pain reduction; speed-of-onset not emphasized but symptomatic relief could allow quicker recovery.
- [Use of ARTRA MSM FORTE in patients with knee osteoarthritis: Results of a randomized open-label comparative study of the efficacy and tolerability of the drug]
PubMed ID: 26978418
Report of faster onset of pain relief and earlier functional improvement with GC+MSM group supports quicker recovery.
Similar by evidence
Supplements the same benefits carry qualifying findings for — a fact about the evidence graph, not a recommendation to swap.
Products with Glucosamine
Search all171 products whose verified label declares Glucosamine — not every bottle that mentions it in a title.
Being studied right now
Recruiting clinical trials registered on ClinicalTrials.gov. A trial in progress has no result yet — this is what the field is asking, not what it found.